JNBA Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

JNBA Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-600	Closed	-$73K	–	618
2018 Q3	$73K	Buy	+600	New	+$70.7K	0.03%	199
2016 Q4	–	Sell	-78	Closed	-$8K	–	864
2016 Q3	$8K	Buy	+78	New	+$7.42K	﹤0.01%	1089
2016 Q2	–	Sell	-51	Closed	-$4K	–	531
2016 Q1	$4K	Buy	+51	New	+$4.56K	﹤0.01%	436
2014 Q1	–	Sell	-150	Closed	-$11K	–	485
2013 Q4	$11K	Buy	+150	New	+$10.6K	0.01%	306

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

JNBA Financial Advisors's IBB Position: Q4 2018 in Review

JNBA Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 600 shares — an estimated $73K sold.

JNBA Financial Advisors first reported a position in IBB in Q4 2013 and held it in 4 quarters. The position peaked at $73K in Q3 2018. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

JNBA Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
JNBA Financial Advisors sold 600 iShares Biotechnology ETF shares in Q4 2018, an estimated $73K.
JNBA Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 4 quarters.
JNBA Financial Advisors's iShares Biotechnology ETF position peaked at $73K in Q3 2018.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on JNBA Financial Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.